Prescription of Anti-Spike Monoclonal Antibodies in COVID-19 Patients with Resistant SARS-CoV-2 Variants in Italy by Daniele Focosi, Marco Tuccori

Get full text

The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19 by Daniele Focosi, Marco Tuccori, Massimo Franchini

Get full text

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies by Daniele Focosi, Marco Tuccori, Andreina Baj, Fabrizio Maggi

Get full text

Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review by Daniele Focosi, Massimo Franchini, Marco Tuccori, Mario Cruciani

Get full text

Editorial: Traditional and innovative approaches for signal detection by Marco Tuccori, Andrew Bate, Andrew Bate, Ugo Moretti, Gianluca Trifirò

Get full text

Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world by Irma Convertino, Luciane Cruz Lopes, Nicole Pratt, Ylenia Ingrasciotta, Marco Tuccori

Get full text

Signal management and risk minimization strategy: a case study on obinutuzumab and non-overt disseminated intravascular coagulation by Giulia Valdiserra, Nadia Mores, Rosalba Elisabetta Rocchi, Laura Sottosanti, Patrizia Felicetti, Pasquale Marchione, Luca Laurenti, Alberto Fresa, Giampaolo Bucaneve, Emiliano Cappello, Marco Bonaso, Sara Ferraro, Irma Convertino, Marco Tuccori, Marco Tuccori

Get full text

Potentially inappropriate drug use in myasthenia gravis: a real-world population-based cohort study in Italy by Giada Crescioli, Giada Crescioli, Marco Finocchietti, Olga Paoletti, Paola Brunori, Francesco Sciancalepore, Marco Tuccori, Marco Tuccori, Antonio Addis, Alfredo Vannacci, Alfredo Vannacci, Niccolò Lombardi, Niccolò Lombardi, Ursula Kirchmayer, The CAESAR study group

Get full text

Riluzole use in presence of contraindications in adults affected by amyotrophic lateral sclerosis and its off-label use in other motor neuron diseases: Findings from an Italian mul... by Giada Crescioli, Giada Crescioli, Marco Finocchietti, Silvia Cascini, Olga Paoletti, David Franchini, Emiliano Cappello, Giulia Valdiserra, Francesco Sciancalepore, Maria Grazia Celani, Marco Tuccori, Marco Tuccori, Alfredo Vannacci, Alfredo Vannacci, Niccolò Lombardi, Niccolò Lombardi, Ursula Kirchmayer, the CAESAR Study Group

Get full text

Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy by Irma Convertino, Massimiliano Cazzato, Silvia Tillati, Sabrina Giometto, Rosa Gini, Giulia Valdiserra, Emiliano Cappello, Sara Ferraro, Marco Bonaso, Claudia Bartolini, Olga Paoletti, Valentina Lorenzoni, Leopoldo Trieste, Matteo Filippi, Giuseppe Turchetti, Michele Cristofano, Corrado Blandizzi, Corrado Blandizzi, Marta Mosca, Ersilia Lucenteforte, Marco Tuccori, Marco Tuccori

Get full text

Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems by Paola Maria Cutroneo, Daniele Sartori, Marco Tuccori, Salvatore Crisafulli, Vera Battini, Carla Carnovale, Concetta Rafaniello, Annalisa Capuano, Elisabetta Poluzzi, Ugo Moretti, Emanuel Raschi

Get full text

Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis by Irma Convertino, Valentina Lorenzoni, Rosa Gini, Giuseppe Turchetti, Elisabetta Fini, Sabrina Giometto, Claudia Bartolini, Olga Paoletti, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Corrado Blandizzi, Marco Tuccori, Ersilia Lucenteforte

Get full text

Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) by Niccolò Lombardi, Giada Crescioli, Alessandra Bettiol, Marco Tuccori, Marco Tuccori, Annalisa Capuano, Roberto Bonaiuti, Alessandro Mugelli, Mauro Venegoni, Giuseppe Danilo Vighi, Alfredo Vannacci, Alfredo Vannacci, the MEREAFaPS Study group, Maria Luisa Aiezza, Alessandra Bettiol, Daria Bettoni, Corrado Blandizzi, Roberto Bonaiuti, Valentina Borsi, Annalisa Capuano, Errica Cecchi, Irma Convertino, Giada Crescioli, Martina Del Lungo, Cristina Di Mauro, Gabriella Farina, Sara Ferraro, Annamaria Fucile, Elena Galfrascoli, Elisabetta Geninatti, Linda Giovannetti, Luca Leonardi, Rosa Liccardo, Niccolò Lombardi, Anna Marra, Eleonora Marrazzo, Giovanna Monina, Alessandro Mugelli, Silvia Pagani, Maria Parrilli, Concetta Rafaniello, Francesco Rossi, Marco Rossi, Stefania Rostan, Marco Ruocco, Marita Sironi, Giulia Spada, Liberata Sportiello, Marco Tuccori, Alfredo Vannacci, Mauro Venegoni, Giuditta Violetta Vighi, Giuseppe Danilo Vighi

Get full text

Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,6... by Ylenia Ingrasciotta, Andrea Spini, Luca L'Abbate, Elena Sofia Fiore, Massimo Carollo, Valentina Ientile, Valentina Isgrò, Anna Cavazzana, Valeria Biasi, Paola Rossi, Lucian Ejlli, Valeria Belleudi, Francesca Poggi, Ester Sapigni, Aurora Puccini, Domenica Ancona, Paolo Stella, Sebastiano Pollina Addario, Alessandra Allotta, Olivia Leoni, Martina Zanforlini, Marco Tuccori, Rosa Gini, Gianluca Trifirò

Get full text

SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study by Laura Augusta Gonella, Francesca Moretti, Annalisa Capuano, Caterina De Sarro, Lorenza Ferrara, Elisabetta Geninatti, Greta Guarnieri, Xhikjana Hysolakoj, Margherita Lalli, Olivia Leoni, Antea Maria Pia Mangano, Patrizia Marani Toro, Viviana Mecchia, Maria Caterina Merlano, Caterina Palleria, Anna Maria Potenza, Paola Rossi, Marco Rossi, Francesca Sanità, Ester Sapigni, Cristina Scavone, Claudia Sommaro, Marco Tuccori, Giovanna Zanoni, Ugo Moretti, VigiVax Working Group

Get full text

Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the “ilmiovaccinoCOVID19 collaborating group” by Nicoletta Luxi, Chiara Bellitto, Francesco Ciccimarra, Emiliano Cappello, Luca L’Abbate, Marco Bonaso, Chiara Ajolfi, Paolo Baldo, Roberto Bonaiuti, Claudio Costantino, Giovambattista De Sarro, Cristina Di Mauro, Giuseppina Fava, Marina Ferri, Alberto Firenze, Fabiana Furci, Luca Gallelli, Luca Leonardi, Giovanna Negri, Fabio Pieraccini, Elisabetta Poluzzi, Chiara Sacripanti, Elisa Sangiorgi, Ester Sapigni, Ilenia Senesi, Roberto Tessari, Luigia Trabace, Alfredo Vannacci, Francesca Venturini, Francesco Vitale, Donatella Zodda, Marco Tuccori, Gianluca Trifirò

Get full text